Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

STELLAR-3 and STELLAR-4 Investigators

Research output: Contribution to journal › Article › peer-review

357 Scopus citations

Fingerprint

Dive into the research topics of 'Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science